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Background: COVID-19 is a global pandemic affecting over 25 million people with more 
than one million deaths and having different patterns of clinical presentation. The study 
aimed to describe the patterns of clinical presentation of COVID-19 patients in Federal 
Medical Centre, Asaba, Nigeria. 
Methods: After obtaining an ethical approval, a facility-based retrospective cross-
sectional study was carried out among 50 eligible patients in the hospital’s isolation ward. 
Data was collected from the patients’ case notes using a proforma to describe the 
epidemiological history, medical history, symptoms, signs, treatment measures and 
complications. Data were analyzed with Statistical Package for Social Science (SPSS) 
version 20 and presented as percentages, mean and standard deviation. 
Results: The mean age of respondents was 44.7 ± 17.3 years with slightly higher 
proportion of female 26 (52.0%) and majority 41 (82.0%) had tertiary level of education. 
Fever 29 (76.3%), followed by malaise 19 (50.0%), cough 18 (47.4%), difficulty with 
breathing 14 (36.8%) and headache 14 (36.8%) were the most common presenting 
symptoms while majority 43 (86.0%) of the respondents had mild to moderate clinical 
presentation. The commonest source of the infection was close contact with confirmed 
case 33 (66.0%). 
Conclusion: Mild to moderate cases of COVID-19 were more, with over two-third of the 
patients being symptomatic. The replication of this study in other COVID-19 treatment 
centers/isolation wards will aid in the better management of COVID-19 patients. 
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In recent times, there has been increased 
incidence of emerging and reemerging 
diseases which has posed a serious public 
health challenge in various regions of the 
world. The last two decades played host to a 
number of viral epidemics such as Severe 
Acute Respiratory Syndrome (SARS) in 
2002-2003, the H1N1 Influenza (Bird flu) in 
2009, Ebola in 2014-2016, Lassa fever in 
20181 and the current COVID-19 
pandemic.2,3 An epidemic of lower 
respiratory tract infections first classified as 
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“pneumonia of unknown etiology” was 
detected in Wuhan, Hubei province in China 
and was first reported to the World Health 
Organization (WHO) Country Office in China 
in December, 2019. Following extensive 
investigation, the causative agent was 
attributed to a novel virus of the coronavirus 
family and experts of the International 
Committee on Taxonomy of Viruses (ICTV) 
named it Severe Acute Respiratory 
Syndrome Coronavirus-2 (SARS-CoV-2). 1,2 
The disease caused by this virus was later 
announced as coronavirus disease 2019 
(COVID-19) by the WHO on the 11th of 
February, 2020. Despite its emergence from 
East Asia, COVID-19 spread rapidly 
worldwide attaining pandemic status and 
declared as such on the 11th of March, 2020. 
Currently, over twenty-five million people 
have been infected with more than 800,000 
deaths globally.3 Most of this exponential 
rise in cases is attributed to community 
transmission of the disease facilitated by 
human to human spread compounded with 
the possibility of transmission by 
asymptomatic carriers.4,5 Disease 
presentation can be typical and atypical. 
Typical presentation of disease refers to the 
traditional signs and symptoms associated 
with diagnosing a disease condition. When 
these signs and symptoms deviate from the 
norm, atypical presentation of disease 
occurs.6 So far, the spectrum of this viral 
illness and patterns of its presentation 
range from asymptomatic infection, mild 
upper respiratory tract illness, severe 
pneumonia with respiratory failure 
(necessitating ventilators) to death.7,8 
Typically, it was reported that patients with 
COVID-19 present with fever, cough and 
difficulty in breathing but with more cases 
reported worldwide and concurrent 
research being carried out, varying patterns 
of presentation continue to emerge.  
Studies done in China amongst patients 
with the disease indicate fever as the most 
common symptom followed by cough, 
dyspnea, myalgia, headache and diarrhoea.5 
Rhinorrhea and sore throat were only noted 
in a few patients.5,7 It was also reported in 
China that amongst adult patients, 
hypertension and cardiovascular disease 
were the most common underlying 
factors/diseases associated with fatality 
followed by diabetes mellitus.5,7,9 Also, a 
study concluded in New York10 found that 
the most common comorbidities were 
hypertension, obesity and diabetes which 
corroborates those done in China. 7,11 In 
Europe, olfactory and gustatory 
dysfunctions have been reported especially 
as patients with COVID-19 exhibited these 
symptoms without rhinorrhea or nasal 
obstruction.4 Severe cases were shown to 
evolve into Acute Respiratory Distress 
Syndrome (ARDS), arrhythmia and septic 
shock while on admission.11 Worthy of note 
is the fact that out of 5,700 patients involved 
in the New York study10, only 1734 (30%) of 
them were febrile which differs from what 
was reported in China with 88- 94% of 
confirmed cases presenting with fever in 
various studies.7,9, There have also been 
reports of young COVID-19 patients in their 
thirties and forties having massive strokes 
without prior history of chronic conditions 
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that may predispose to cerebrovascular 
accident.12 
The first case of COVID-19 in Nigeria was 
confirmed on 27th February, 2020 and since 
then the country has recorded over 54,000 
cases with slightly over 1000 deaths. The 
case fatality rate has gradually declined 
from about 3.54% to the present rate of 
1.9% as at 30th of August, 2020.13 The 
Nigeria Center for Disease Control (NCDC) 
has continuously revised the case 
definitions for COVID-19 as more data came 
to light, therefore the clinical presentation 
for inclusion as a case has also undergone 
five modifications (four case definitions and 
one community case definition) and the last 
one was in May 2020, the community case 
definition. The most recent case definitions 
include Suspected Case which is defined as 
any person (including severely ill patients) 
presenting with fever, cough or difficulty in 
breathing AND who within 14 days before 
the onset of illness had any of the following 
exposures: History of travel to and more 
than 24 hours transit through any high risk 
country with widespread community 
transmission of SARS-CoV-2 OR Close 
contact with a confirmed case of COVID-19 
OR Exposure to a healthcare facility where 
COVID-19 case(s) have been reported; 
Probable Case was defined as any suspected 
case whose test result for COVID-19 is 
indeterminate OR whose test result is 
positive on a pan-coronavirus assay OR 
where samples were not collected before the 
demise of a suspect case and; Confirmed 
Case was defined as any person with 
laboratory confirmation of SARS-CoV-2 
infection with or without signs and 
symptoms.14 
The aim of this study was to describe the 
patterns of clinical presentation of COVID-
19 patients in Federal Medical Centre, 
Asaba. Studies so far published on patterns 
of clinical presentation of COVID-19 have 
not extensively described those from Delta 
State where the Federal Medical Centre, 
Asaba is situated. We therefore believe that 
the outcome of this study will add to the 
growing body of knowledge of COVID-19 and 
assist clinicians in prompt identification 




This study was carried out at the Centre for 
Communicable Diseases’ Control and 
Research (CCDCR) Federal Medical Centre, 
Asaba, Delta State. Delta State has an 
estimated population of 5,818,176 as at 
2020 projected from the 2006 census figure 
(4,100,000) at a growth rate of 2.5%. 15 It is 
a predominantly oil and agricultural 
producing state located in the South-South 
region of Nigeria. The capital city, Asaba, 
plays host to the Federal Medical Centre, a 
tertiary health institution which is a 320 
bedded facility providing tertiary health care 
services to patients within Delta and 
contiguous states. It has a Centre for 
Communicable Diseases’ Control and 
Research (CCDCR) which operates the 
isolation ward, with twelve (12) en-suite 
rooms consisting of ten (10) treatment 
rooms and two (2) holding rooms.  
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It is operated by a team of medical doctors 
from all specialties. Pharmacists, laboratory 
scientists, nurses, hygienists, environ-
mental health officers and biomedical 
engineers are among other health care 
providers engaged in the Centre. The Centre 
is purpose-built and provides services to 
infectious/communicable diseases patients 
while complying with the Nigeria Centre for 
Disease and Control (NCDC) guidelines and 
international best practices on the control 
and management of communicable diseases 
including COVID-19 infection. 
Study Design 
This was a facility-based retrospective 
cross-sectional study design  
Study Population 
All case notes of confirmed cases of COVID-
19 admitted and managed in the CCDCR’s 
isolation ward at the Federal Medical 
Centre, Asaba, between April and July, 
2020.  
Inclusion Criteria 
All case notes of confirmed cases whose first 
contact (were not transferred in or referred 
from other COVID-19 managing facilities), 
admission and treatment was in Federal 
Medical Centre, Asaba, CCDCR isolation 
ward between April-July, 2020. This was in 
order to reduce non-uniformity of data and 
to be able to triage unbiasedly and thereby 
reducing information bias, from being a 
major limitation of the study. 
 
 
Sample size and Sampling method 
The various patients’ case notes were 
screened for completeness by the 
researchers and assistants and only case 
notes that met the study inclusion and 
exclusion criteria were selected. All eligible 
patients’ case notes within the specified 
period of April to July 2020 were included in 
the study. This came to a total of fifty case 
notes from the seventy-one total admission 
at the isolation ward of CCDCR, Federal 
Medical Centre, Asaba for the period 
specified.  
Methods of Data Collection 
Two research assistants were trained on 
data collection from the case notes and data 
entry for a week. These are resident doctors 
that were part of the COVID-19 
management team of the centre from 
inception of the pandemic. 
Data for the study was collected from the 
selected eligible patient’s case notes with 
review of presenting complaints, history 
taking, examination, charts, treatment and 
nursing records. These were categorized 
into sections: Section A being socio-
demographics of the patients and duration 
of admission; Section B included questions 
on patterns of presentations (fever, cough, 
respiratory distress, difficulty in breathing, 
loss of smell, loss of taste,)  which was 
modified and adapted from recent studies 
on COVID-19 and Section C had questions 
on clinical presentation  and management, 
presence of other comorbidities such as 
hypertension, diabetes mellitus, kidney 
diseases, and treatment uptake i.e. use of 
dexamethasone, intubation, oxygenation 
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etc. Information retrieved included 
epidemiological history (age, sex, ethnicity, 
possible place of infection), current and past 
medical history, symptoms, signs, 
confirmed laboratory results, treatment 
measures and complications. All the data 
collected were scrutinized by two physicians 
and interpretation were compared to ensure 
uniformity. Social class classification in this 
study was according to the UK National 
Statistics-Socio-Economic Classification 
(NS-SEC).16 In 2001, the Registrar General 
Society Class (RGSC) was replaced with the 
National Statistics-Socio-Economic 
Classification (NS-SEC) to reflect current 
perceptions of both occupations and 
occupational advantage more accurately, 
from non-manual and manual groups into 
eight groups. These are: 1). Higher 
managerial and Professional occupations 
e.g. doctors, dentists, lawyers and 
engineers. 2). Lower managerial and 
professional occupations e.g. school 
teachers, nurses, police sergeants, 
journalists. 3). Intermediate occupations 
e.g. airline cabin crew, secretaries. 4). Small 
employers and own account workers e.g. 
self-employed, builders and hairdressers. 
5). Lower supervisory and technical 
occupations e.g. train drivers, plumbers, 
electricians. 6). Semi-routine occupations 
e.g. shop assistants, post men, care 
assistants. 7). Routine occupations e.g. bus 
drivers, waitresses, cleaners and 8). Never 
worked and long-term unemployed e.g. the 
unemployed and those who have never had 
a paying job. 
In this study, pattern of clinical 
presentation was taken as the presenting 
symptoms and signs of the patients as 
documented in the selected cases notes of 
the patients in addition to the required 
COVID-19 clinical management of the 
patients. They were then grouped as 
mild/moderate, severe and critical. 
Data Analysis 
Data were then coded, entered and analyzed 
using the SPSS version 20.0 software. 
Discrete variables such as educational 
status and marital status were presented as 
percentages while continuous variables that 
are normal in distribution (such as age) 
were expressed as mean ± standard 
deviation.  
Ethical Considerations 
Ethical clearance (FMC/ASB/A81 VOL 
X11/137) to conduct this research was 
obtained from the Federal Medical Centre, 
Asaba, Ethics and Research Committee. 
Permission was also sought from the 
Director of the Centre of Communicable 
Disease Control and Research, Federal 
Medical Centre, Asaba and the Head, 
Department of Public Health of the hospital. 
All data were kept secure and made 
available to only members of the research 
team. 
RESULTS 
Table 1 shows the socio-demographic 
characteristics of the patients with a mean 
age of 44.7 ± 17.3 years and a greater 
proportion 26 (52.0%) being in the age group 
of 20-49 years. Almost two-thirds 33 
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(66.0%) were married while all the 
participants were Christians. Over 80.0% of 
the patients had tertiary education and 28 
(58.0%) belonged to social class 1 
comprising of higher managerial and 
professional occupations. Nineteen (38.0%) 
of the respondents were of the Igbo ethnic 
group. 
The most reported possible sources of the 
infection amongst the patients was being in 
close contact with a confirmed COVID-19 
case 33 (66.0%), 19 (38.0%) had been to a 
health facility where COVID-19 was being 
managed while 3 (6.0%) had contact with a 
confirmed COVID-19 case in addition to 
exposure to a health facility where COVID-
19 was being managed. (Table 2) 
Table 3 revealed that twelve (24.0%) of the 
patients were asymptomatic at presentation 
while 38 (76.0%) were symptomatic. 
Regarding the presenting clinical signs and 
symptoms of patients, 29 (76.3%) had fever, 
followed by malaise 19 (50.0%), cough 18 
(47.4%), difficulty with breathing 14 (36.8%) 
and headache 14 (36.8%) being the most 
common presenting symptoms. Others were 
loss of appetite 13 (34.2%), loss of smell 13 
(34.2%) and loss of taste 13 (34.2%), among 
others. Majority 43 (86.0%) of the patients 
had mild to moderate pattern of clinical 
presentation, 5 (10.0%) were severe and 2 
(4.0%) were in critical condition as at time of 
presentation. 
Anti-hypertensive was the most 14 (28%) 
commonly used medications followed by use 
of oxygen and oral hypoglycaemic 
medications with 5 (10.0%) and 3 (6.0%), 
respectively while only 1 (2%) had 
intubation procedure done. Two of the fifty 
patients died, giving a percentage of 4.0% 
and they were both in the age group of 50 – 
79 years. (Table 4) 
 
 






Age groups (years)   
1 – 19 3 6.0 
20 – 49 26 52.0 




Male 24 48.0                                       
Female 26 52.0 
Marital status    
Single 12 24.0 
Married 33 66.0 
Widowed   5 10.0 
Religion     
Christianity 50 100.0 
Islam 0  0.0 
Level of Education    
None 1 2.0 
Primary 2 4.0 
Secondary 6 12.0 
Tertiary 41 82.0 
Social class   
Class 1 28 56.0 
Class 2 7 14.0               













Ethnicity     
Igbo 19 38.0 
Delta Ibo 11 22.0 
Yoruba 1 2.0  
Urhobo 13 26.0 
Isoko 4 8.0 
Esan 1 2.0 
Itsekiri 2 4.0                                                        
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Table 2:  Patients Possible Source of COVID-19 infection 
 
*Possible Source of infection                                Frequency 
                                   (n=50) 
              
Percent 
Close Contact with a confirmed COVID-19 Case        33                    66.0 
 
Exposure to health facility where COVID-19 was managed 
       
       19                      
                 
38.0 
 
Exposure to health facility where COVID-19 was being managed and 
close contact to a confirmed COVID-19 case 
       
         3                 
                 




Table 3:  Presenting Signs/Symptoms and Disease severity of patients 
 
Variable Frequency Percent  
Presence of Symptom(s) (n=50)   
Yes 38 76.0 




Fever 29 76.3 
Malaise    19                                                   50.0 
Cough 18 47.4 
Headache 14 36.8 
Breathing Difficulty 14 36.8 
Loss of appetite 13 34.2 
Loss of smell                                                                                      13 34.2 
Loss of taste 13                                 34.2 
Frequent stooling 10 26.3 
Body pains 8 21.1 
Respiratory distress 7 18.4 
Vomiting 5 13.2                                       
Sore throat 4 10.5 
Runny nose/catarrh 2 5.3  
Limb weakness  2 5.3 
 
Disease severity (n=50) 
  
Mild/Moderate 43 86 
Severe 5 10 
Critical 2 4 
*Multiple response  
 
DISCUSSION 
Over half of the patients were in the age 
group of 20-49 years with a mean age of 
44.7 ±17.3 years. This was not surprising as 
the SARS-CoV-2 infection has been 
documented to affect all age groups even 
more with increasing age. This finding could 
be attributed to the fact that the 
economically productive adults are in this 
age bracket, constituting the workforce that 
goes out to work daily and therefore more 
likely to be exposed to SARS-CoV-2 virus. 
This was at variance with findings from 
other studies where the mean age of 
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Table 4:  Treatment uptake and outcome of Patients 
 
Variable Frequency (n=50) Percent  
Treatment Uptake   
Antihypertensive medication 14 28.0 
Oxygenation 5 10.0 
Oral Hypoglycaemic medication 3 6.0 
Blood transfusion 2 4.0 
Anticonvulsant 2 4.0  
Dexamethasone 1 2.0 
Intubation 1 2.0 
 
Treatment Outcome 
                    
Recovered 48 96                              
Died 2 4                                
The variance in these findings could 
possibly be due to the type of demographic 
population curve/transition in the countries 
of study like China that may have a young 
population or an aging population, giving 
room for either more deaths among the 
young or older/dependent age group.  
There were three children with COVID-19 in 
this study, with age ranging from 1-12 years 
old. They were all close contacts of a 
confirmed case of COVID-19 in the family 
which is in keeping with findings from a 
study in Katsina, Nigeria where all five 
paediatric cases had close contact with a 
family member with confirmed COVID-19 
infection.19 The findings of this study and 
that of Katsina corroborates what was 
reported in the largest paediatric COVID-19 
bio-specimen repository in Massachusetts 
where it was found that children could have 
high levels of the virus in their upper 
airways but yet displays relatively mild or no 
symptoms.19,20 There was an almost equal 
proportion of male to female patients’ ratio, 
as female were slightly more than male 
patients, a finding which is consistent with 
a multicenter European study4 but 
inconsistent with reports from several 
studies conducted in China that showed a 
male preponderance of the disease.2,5,7,8,21 
This was also inconsistent with the Nigeria 
Center for Disease Control (NCDC) report 
showing that males were twice more likely to 
contact COVID-19 than females.22 The 
slightly higher female dominance in this 
study may be attributed to better health 
seeking behaviour of females, as there has 
been several documentation of better health 
seeking behaviour among women.23,24  
Better health seeking behaviour may not 
only result in reduced morbidity and 
mortality but will also lead to reduced 
financial burden and better quality of life. 
All the respondents were Christians and 
greater proportion were of Igbo ethnicity. 
The predominance of Christianity could be 
attributed to the study being carried out in 
the South-South region of the country, 
where the treatment centre is located given 
that a larger proportion of the people in the 
South-South practice Christianity.25 In 
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addition to the above, majority of our 
patients had tertiary level of education and 
were skilled workers, which ultimately 
would result in better health seeking 
behaviour and health care. The most 
common possible source of infection in this 
study was being in close contact with a 
confirmed COVID-19 case, followed by 
attending a health facility where COVID-19 
was being managed. This corroborates the 
conclusion of person to person transmission 
as has been earlier documented.11 The 
possible contributory factor was that at the 
start of the COVID-19 pandemic in Nigeria, 
there was this high belief that it was a hoax 
and therefore not real. This, compounded 
with the poor or non-existent practice of 
infection prevention and control measures 
exposed many to the infection due to close 
contact with confirmed and unconfirmed 
COVID-19 cases. This finding is in-tandem 
with findings from studies done in other 
parts of the world where infection 
prevention and control measures were not 
properly implemented early.26,27 The belief 
by many that the disease is a hoax or 
propaganda may have inadvertently led to 
non-acceptance of death being due to the 
disease by relatives.  
About two-third of the patients presented 
with symptoms and among the clinical 
symptoms the most common ones included 
fever, malaise, cough, headache and 
difficulty with breathing. These were in-
tandem with the clinical pattern of COVID-
19 as published by the WHO and NCDC. 
13,16 The loss of appetite, smell and taste 
lends credence to reports of olfactory and 
gustatory dysfunctions as part of the clinical 
presentation of COVID-19, especially in 
mild to moderate cases.4 This presentation 
of over two-thirds of the patients being 
symptomatic could probably have been due 
to the study being facility-based and 
conducted in a COVID-19 treatment centre. 
As majority of patients that presented for 
care would have been sick somewhat with 
signs and symptoms in need of expert 
medical care, needing treatment especially 
in the face of many people assuming the 
disease was a hoax.  
The mild to moderate pattern of clinical 
presentation of the patients was more, while 
severe and critical presentations were few. 
Patients with severe and critical 
presentations required not only 
hospitalization for treatment but also 
needed oxygen support and advanced 
intensive care such as intubation. The 
finding of  majority of the patients 
presenting clinically as mild to moderate 
cases was in keeping with findings from 
other studies1,8 and also in line with the 
Nigeria Centre for Disease Control 14 and 
World Health Organization clinical 
documentations on COVID-19 
management.17,18 Part of what may have 
contributed to the low rate of critical and 
severe clinical presentations as found by 
this study could be the young population of 
the patients and the relatively low rate of 
comorbidities among the patients. 
Associated comorbidities such as diabetes 
mellitus and hypertension in addition to 
older age have been documented to 
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negatively affect outcome and prognosis of 
the disease.26,27 
A meta-analysis conducted by Morgan 
Spencer Gold et al revealed high prevalence 
of diabetes mellitus among fatal cases of 
COVID-19 which may have resulted in the 
innate immunity being compromised 
amongst these group of patients28 The study 
by Sanyaolu A et al reported increased 
severity of COVID-19 in patients with type 2 
diabetes mellitus and an all-round 
increased mortality rate with poor glycaemic 
control.29 Fortunately, this was not recorded 
in this study. This study recorded two 
deaths which were in those 50 – 79 years. 
This could partly be due to older age, as 
many studies5,7,8,29 have documented 
increasing age as part of the possible 
determinant resulting in poor prognosis. 
Limitations in this study are the small 
sample size and that it could be prone to 
differential documentation, as data was 
retrieved from documented case notes of the 
patients, which may limit interpretation of 
our findings. 
Conclusion: Majority of the patients 
presented as mild to moderate cases of 
COVID-19 with over two-thirds of them 
presenting symptomatic at the Federal 
Medical Centre, Asaba CCDCR isolation 
ward. The patterns of clinical presentations, 
are in keeping with that of WHO and NCDC 
case definitions and those described by 
previous studies. We therefore believe that 
the outcome of this study will add to the 
growing body of knowledge of COVID-19 
infection and assist clinicians in prompt 
identification and triaging of patients 
presenting with the disease. The replication 
of this study in other COVID-19 treatment 
centers/isolation wards will aid in the better 
management of suspected and confirmed 
COVID-19 patients. Hospital administra-
tors/management and Medical Directors 
can draw up Standard Operating 
Procedures (SOPs) and protocols on proper 
description of patterns of clinical 
presentations of COVID-19 to be used in 
their facilities, to guide in the management 
of these patients as they present. Lastly, 
health care workers at all levels of care, 
should not only watch out for these signs 
and symptoms of the COVID-19 disease in 
presenting patients, they should also apply 
these presenting signs and symptoms 
efficiently in line with the recommended 
case definitions with the mind set of 
achieving correct patterns of clinical 
presentation. As doing this will improve the 
management of these patients, reduce 
consequential morbidities and possible 
mortality from the COVID-19 disease. 
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